Validation of Academic Research Consortium for High Bleeding Risk Definition in East-Asian Patients
{{output}}
Background: Clinical applicability of the Academic Research Consortium High Bleeding Risk (ARC-HBR) criteria in East-Asian patients receiving potent antiplatelet therapy for acute coronary syndromes (ACS) is still undetermined. ... ...
